title: Faecal microbiota transplantation in 2013: developing human gut microbiota as a class of therapeutics.
abstract: Although the idea of faecal transplantation dates back many decades, only with advances in scientific technologies can we begin systematic development of this new class of therapeutics. The primary focus remains on treatment of Clostridium difficile infection—new applications are beginning to emerge, but a long journey remains ahead.
authors.affiliation: University of Minnesota, Department of Medicine, Division of Gastroenterology and Centre for Immunology, 2101 6th Street S.E., Minneapolis, MN 55414, USA.
authors.forename: Alexander
authors.initials: A
authors.lastname: Khoruts
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000494:pharmacology; D003015:Clostridium Infections / Q000628:therapy*; D005243:Feces / Q000382:microbiology; D041981:Gastrointestinal Tract / Q000382:microbiology*; D054884:Host-Pathogen Interactions / Q000502:physiology; D006801:Humans; D064307:Microbiota / Q000187:drug effects / Q000502:physiology*; D013812:Therapeutics / Q000639:trends*; D014180:Transplantation
chemical_list: D000900:Anti-Bacterial Agents